Aggression in autism spectrum disorder: presentation and treatment options

References

• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders: DSM-5Spring Hill, TNManMag2003
   Google Scholar
• HastingsRPKovshoffHWardNJdegli EspinosaFBrownTRemingtonBSystems analysis of stress and positive perceptions in mothers and fathers of pre-school children with autismJ Autism Dev Disord200535563564416177837
   PubMed Web of Science ®Google Scholar
• LecavalierLLeoneSWiltzJThe impact of behaviour problems on caregiver stress in young people with autism spectrum disordersJ Intellect Disabil Res200650317218316430729
   PubMed Web of Science ®Google Scholar
• AmanMSinghNAberrant Behavior Checklist: ManualEast Aurora, NYSlosson Educational Publications1986
   Google Scholar
• KaartinenMPuuraKHelminenMSalmelinRPelkonenEJuujärviPReactive aggression among children with and without autism spectrum disorderJ Autism Dev Disord201444102383239123263769
   PubMed Web of Science ®Google Scholar
• FarmerCButterEMazurekMOAggression in children with autism spectrum disorders and a clinic-referred comparison groupAutism201519328129124497627
   PubMed Web of Science ®Google Scholar
• HartleySSikoraDMcCoyRPrevalence and risk factors of maladaptive behaviour in young children with autistic disorderJ Intellect Disabil Res2008521081982918444989
   PubMed Web of Science ®Google Scholar
• LoveJRCarrJELeBlancLAFunctional assessment of problem behavior in children with autism spectrum disorders: a summary of 32 outpatient casesJ Autism Dev Disord200939236337218704671
   PubMed Web of Science ®Google Scholar
• McClintockKHallSOliverCRisk markers associated with challenging behaviours in people with intellectual disabilities: a meta-analytic studyJ Intellect Disabil Res200347640541612919191
   PubMed Web of Science ®Google Scholar
• TsakanikosECostelloHHoltGSturmeyPBourasNBehaviour management problems as predictors of psychotropic medication and use of psychiatric services in adults with autismJ Autism Dev Disord20073761080108517053989
   PubMed Web of Science ®Google Scholar
• KanneSMMazurekMOAggression in children and adolescents with ASD: prevalence and risk factorsJ Autism Dev Disord201141792693720960041
   PubMed Web of Science ®Google Scholar
• MatsonJLRivetTTThe effects of severity of autism and PDD-NOS symptoms on challenging behaviors in adults with intellectual disabilitiesJ Dev Phys Disabil20082014151
   Web of Science ®Google Scholar
• NICHD Early Child Care Research NetworkTrajectories of physical aggression from toddlerhood to middle childhood: predictors, correlates, and outcomesMonogr Soc Res Child Dev2004694vii1129
   Google Scholar
• EisenhowerASBakerBLBlacherJPreschool children with intellectual disability: syndrome specificity, behaviour problems, and maternal well-beingJ Intellect Disabil Res200549965767116108983
   PubMed Web of Science ®Google Scholar
• ReeseRMRichmanDMBelmontJMMorsePFunctional characteristics of disruptive behavior in developmentally disabled children with and without autismJ Autism Dev Disord200535441942816134028
   PubMed Web of Science ®Google Scholar
• DominickKCDavisNOLainhartJTager-FlusbergHFolsteinSAtypical behaviors in children with autism and children with a history of language impairmentRes Dev Disabil200728214516216581226
   PubMed Web of Science ®Google Scholar
• LuiselliJKAggression and noncomplianceApplied Behavior Analysis for Children with Autism Spectrum DisordersBerlin, GermanySpringer2009175187
   Google Scholar
• Dryden-EdwardsRCCombrinck-GrahamLDevelopmental Disabilities from Childhood to Adulthood: What Works for Psychiatrists in Community and Institutional SettingsBaltimore, MDJHU Press2010
   Google Scholar
• DagnanDWestonCPhysical intervention with people with intellectual disabilities: the influence of cognitive and emotional variablesJ Appl Res Intellect Disabil2006192219222
   Web of Science ®Google Scholar
• StithSMLiuTDaviesLCRisk factors in child maltreatment: a meta-analytic review of the literatureAggress Violent Behav20091411329
   Web of Science ®Google Scholar
• Otero-LópezJMCastroCVillardefrancosESantiagoMJJob dissatisfaction and burnout in secondary school teachers: student’s disruptive behaviour and conflict management examinedEur J Educ Psychol20092299111
   Google Scholar
• NeeceCLGreenSABakerBLParenting stress and child behavior problems: a transactional relationship across timeAm J Intellect Dev Disabil20121171486622264112
   PubMedGoogle Scholar
• HodgettsSNicholasDZwaigenbaumLHome sweet home? Families’ experiences with aggression in children with autism spectrum disordersFocus Autism Dev Disabil2013283166174
   Web of Science ®Google Scholar
• PowersMDPalmieriMJD’EramoKSPowersKMEvidence-based treatment of behavioral excesses and deficits for individuals with autism spectrum disordersEvidence-based Practices and Treatments for Children with AutismNew York, NYSpringer20115592
   Google Scholar
• SooryaLCarpenterLRomanczykRApplied behavior analysis. Textbook of Autism Spectrum DisordersArlington, VAAmerican Psychiatric Publishing2011525536
   Google Scholar
• CooperJOHeronTEHewardWLApplied Behavior Analysis2nd edNew York, NYPearson2007
   Google Scholar
• WongCOdomSLHumeKAEvidence-based practices for children, youth, and young adults with autism spectrum disorder: a comprehensive reviewJ Autism Dev Disord20154571951196625578338
   PubMed Web of Science ®Google Scholar
• RothMEGillisJMReedFDA meta-analysis of behavioral interventions for adolescents and adults with autism spectrum disordersJ Behav Educ2014232258286
   Google Scholar
• IwataBADorseyMFSliferKJBaumanKERichmanGSToward a functional analysis of self-injuryJ Appl Behav Anal19942721978063622
   PubMed Web of Science ®Google Scholar
• PaclawskyjTRMatsonJLRushKSSmallsYVollmerTRQuestions about behavioral function (QABF): a behavioral checklist for functional assessment of aberrant behaviorRes Dev Disabil200021322322910939320
   PubMed Web of Science ®Google Scholar
• IwataBADeLeonIGRoscoeEMReliability and validity of the functional analysis screening toolJ Appl Behav Anal201346127128424114099
   PubMed Web of Science ®Google Scholar
• NewcomerLLLewisTJFunctional behavioral assessment: an investigation of assessment reliability and effectiveness of function-based interventionsJ Emot Behav Disord2004123168181
   Web of Science ®Google Scholar
• HerzingerCVCampbellJMComparing functional assessment methodologies: a quantitative synthesisJ Autism Dev Disord20073781430144517004118
   PubMed Web of Science ®Google Scholar
• BadgettNFalcomataTSA comparison of methodologies of brief functional analysisDev Neurorehabil201518422423323869515
   PubMed Web of Science ®Google Scholar
• QuerimACIwataBARoscoeEMSchlichenmeyerKJOrtegaJVHurlKEFunctional analysis screening for problem behavior maintained by automatic reinforcementJ Appl Behav Anal2013461476024114084
   PubMed Web of Science ®Google Scholar
• HardingJWWackerDPBergWKLeeJFDolezalDConducting functional communication training in home settings: a case study and recommendations for practitionersBehav Anal Pract2009212120936098
   PubMedGoogle Scholar
• FersterCBPositive reinforcement and behavioral deficits of autistic childrenChild Dev19613243745613699189
   PubMed Web of Science ®Google Scholar
• MatsonJLDixonDRMatsonMLAssessing and treating aggression in children and adolescents with developmental disabilities: a 20-year overviewEduc Psychol2005252–3151181
   Google Scholar
• GerhardtPFWeissMJDelmolinoLTreatment of severe aggression in an adolescent with autism: non-contingent reinforcement and functional communication trainingBehav Anal Today200444386
   Google Scholar
• CarrJECoriatySWilderDAA review of “noncontingent” reinforcement as treatment for the aberrant behavior of individuals with developmental disabilitiesRes Dev Disabil200021537739111100801
   PubMed Web of Science ®Google Scholar
• CarrEGDurandVMReducing behavior problems through functional communication trainingJ Appl Behav Anal19851821111262410400
   PubMed Web of Science ®Google Scholar
• BraithwaiteKLRichdaleALFunctional communication training to replace challenging behaviors across two behavioral outcomesBehav Interv20001512136
   Web of Science ®Google Scholar
• SchieltzKMWackerDPHardingJWIndirect effects of functional communication training on non-targeted disruptive behaviorJ Behav Educ2011201153223487563
   PubMedGoogle Scholar
• KurtzPFBoelterEWJarmolowiczDPChinMDHagopianLPAn analysis of functional communication training as an empirically supported treatment for problem behavior displayed by individuals with intellectual disabilitiesRes Dev Disabil20113262935294221696917
   PubMed Web of Science ®Google Scholar
• BlankenshipKEricksonCAMcDougleCJPharmacotherapy of autism and related disordersPsychiatr Ann2010404203209
   Web of Science ®Google Scholar
• McCrackenJTMcGoughJShahBRisperidone in children with autism and serious behavioral problemsN Engl J Med2002347531432112151468
   PubMed Web of Science ®Google Scholar
• OwenRSikichLMarcusRNAripiprazole in the treatment of irritability in children and adolescents with autistic disorderPediatrics200912461533154019948625
   PubMed Web of Science ®Google Scholar
• CenterWatchDrug Information: FDA-Approved DrugsSilver Spring, MDUS Food and Drug Administration2009 Available from: http://www.centerwatch.com/drug-information/fda-approved-drugs/year/2009Accessed April 26, 2016
   Google Scholar
• HorriganJPBarnhillLJRisperidone and explosive aggressive autismJ Autism Dev Disord19972733133239229261
   PubMed Web of Science ®Google Scholar
• McDougleCJHolmesJPCarlsonDCPeltonGHCohenDJPriceLHA double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disordersArch Gen Psychiatry19985576336419672054
   PubMed Web of Science ®Google Scholar
• SheaSTurgayACarrollARisperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disordersPediatrics20041145e634e64115492353
   PubMed Web of Science ®Google Scholar
• Research Units on Pediatric Psychopharmacology Autism NetworkRisperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 monthsAm J Psychiatry200516271361136915994720
   PubMed Web of Science ®Google Scholar
• AmanMRettigantiMNagarajaHNTolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trialJ Child Adolesc Psychopharmacol201525648249326262903
   PubMed Web of Science ®Google Scholar
• EricksonCAStiglerKAPoseyDJMcDougleCJAripiprazole in autism spectrum disorders and fragile X syndromeNeurotherapeutics20107325826320643378
   PubMed Web of Science ®Google Scholar
• StiglerKAPoseyDJMcDougleCJAripiprazole for maladaptive behavior in pervasive developmental disordersJ Child Adolesc Psychopharmacol200414345546315650503
   PubMed Web of Science ®Google Scholar
• Valicenti-McDermottMRDembHClinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilitiesJ Child Adolesc Psychopharmacol200616554956017069544
   PubMed Web of Science ®Google Scholar
• StiglerKADienerJTKohnAEAripiprazole in pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 14-week, prospective, open-label studyJ Child Adolesc Psychopharmacol200919326527419519261
   PubMed Web of Science ®Google Scholar
• MarcusRNOwenRKamenLA placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorderJ Am Acad Child Adolesc Psychiatry200948111110111919797985
   PubMed Web of Science ®Google Scholar
• MarcusRNOwenRManosGAripiprazole in the treatment of irritability in pediatric patients (aged 6–17 years) with autistic disorder: results from a 52-week, open-label studyJ Child Adolesc Psychopharmacol201121322923621663425
   PubMed Web of Science ®Google Scholar
• HoJGCaldwellRLMcDougleCJThe effects of aripiprazole on electrocardiography in children with pervasive developmental disordersJ Child Adolesc Psychopharmacol201222427728322849533
   PubMed Web of Science ®Google Scholar
• LallyJMacCabeJHAntipsychotic medication in schizophrenia: a reviewBr Med Bull2015114116917925957394
   PubMed Web of Science ®Google Scholar
• LiXBTangYLWangCYde LeonJClozapine for treatment-resistant bipolar disorder: a systematic reviewBipolar Disord201517323524725346322
   PubMed Web of Science ®Google Scholar
• IfteniPCorrellCUNielsenJBurteaVKaneJMManuPRapid clozapine titration in treatment-refractory bipolar disorderJ Affect Disord201416616817225012427
   PubMed Web of Science ®Google Scholar
• PoyrazCATuranŞDemirelÖFUsta SağlamNGYıldızNDuranAEffectiveness of ultra-rapid dose titration of clozapine for treatment-resistant bipolar mania: case seriesTher Adv Psychopharmacol20155423724226301080
   PubMedGoogle Scholar
• PoyrazCAÖzdemirASağlamNGRapid clozapine titration in patients with treatment refractory schizophreniaPsychiatr Q201687231532226433727
   PubMed Web of Science ®Google Scholar
• ChenNCBedairHSMcKayBBowersMBJrMazureCClozapine in the treatment of aggression in an adolescent with autistic disorderJ Clin Psychiatry200162647948011465533
   PubMed Web of Science ®Google Scholar
• GobbiGPulvirentiLLong-term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behaviourJ Psychiatry Neurosci200126434034111590976
   PubMed Web of Science ®Google Scholar
• LambreySFalissardBMartin-BarreroMEffectiveness of clozapine for the treatment of aggression in an adolescent with autistic disorderJ Child Adolesc Psychopharmacol2010201798020166802
   PubMed Web of Science ®Google Scholar
• BeherecLLambreySQuiliciGRosierAFalissardBGuillinORetrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviorsJ Clin Psychopharmacol201131334134421508854
   PubMed Web of Science ®Google Scholar
• AyubMSaeedKMunshiTANaeemFClozapine for psychotic disorders in adults with intellectual disabilitiesCochrane Database Syst Rev20159CD01062526397173
   PubMed Web of Science ®Google Scholar
• MaayanLCorrellCUWeight gain and metabolic risks associated with antipsychotic medications in children and adolescentsJ Child Adolesc Psychopharmacol201121651753522166172
   PubMed Web of Science ®Google Scholar
• HorriganJPBarnhillLJCourvoisieHEOlanzapine in PDDJ Am Acad Child Adolesc Psychiatry1997369116611679291716
   PubMed Web of Science ®Google Scholar
• HollanderEWassermanSSwansonENA double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorderJ Child Adolesc Psychopharmacol200616554154817069543
   PubMed Web of Science ®Google Scholar
• PotenzaMNHolmesJPKanesSJMcDougleCJOlanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot studyJ Clin Psychopharmacol199919137449934941
   PubMed Web of Science ®Google Scholar
• KemnerCWillemsen-SwinkelsSHde JongeMTuynman-QuaHvan EngelandHOpen-label study of olanzapine in children with pervasive developmental disorderJ Clin Psychopharmacol200222545546012352267
   PubMed Web of Science ®Google Scholar
• FidoAAl-SaadSOlanzapine in the treatment of behavioral problems associated with autism: an open-label trial in KuwaitMed Princ Pract200817541541818685284
   PubMed Web of Science ®Google Scholar
• MartinAKoenigKScahillLBregmanJOpen-label quetiapine in the treatment of children and adolescents with autistic disorderJ Child Adolesc Psychopharmacol1999929910710461820
   PubMed Web of Science ®Google Scholar
• FindlingRLMcNamaraNKGraciousBLQuetiapine in nine youths with autistic disorderJ Child Adolesc Psychopharmacol200414228729415319025
   PubMed Web of Science ®Google Scholar
• CorsonAHBarkenbusJEPoseyDJStiglerKAMcDougleCJA retrospective analysis of quetiapine in the treatment of pervasive developmental disordersJ Clin Psychiatry200465111531153615554768
   PubMed Web of Science ®Google Scholar
• HardanAYJouRJHandenBLRetrospective study of quetiapine in children and adolescents with pervasive developmental disordersJ Autism Dev Disord200535338739116119479
   PubMed Web of Science ®Google Scholar
• GoforthHWRaoMSImprovement in behaviour and attention in an autistic patient treated with ziprasidoneAust N Z J Psychiatry200337677577614636398
   PubMed Web of Science ®Google Scholar
• DuggalHSZiprasidone for maladaptive behavior and attention-deficit/hyperactivity disorder symptoms in autistic disorderJ Child Adolesc Psychopharmacol200717226126417489724
   PubMed Web of Science ®Google Scholar
• McDougleCJKemDLPoseyDJCase series: use of ziprasidone for maladaptive symptoms in youths with autismJ Am Acad Child Adolesc Psychiatry200241892192712164181
   PubMed Web of Science ®Google Scholar
• MaloneRPDelaneyMAHymanSBCaterJRZiprasidone in adolescents with autism: an open-label pilot studyJ Child Adolesc Psychopharmacol200717677979018315450
   PubMed Web of Science ®Google Scholar
• DominickKWinkLKMcDougleCJEricksonCAA retrospective naturalistic study of ziprasidone for irritability in youth with autism spectrum disorderJ Child Adolesc Psychopharmacol201525539740126091194
   PubMed Web of Science ®Google Scholar
• TaylorDZiprasidone in the management of schizophreniaCNS Drugs200317642343012697001
   PubMed Web of Science ®Google Scholar
• KarlssonPDenckerENybergSPharmacokinetics, dopamine D2 and serotonin 5-HT2A receptor occupancy and safety profile of paliperidone ER, in healthy volunteersEur Neuropsychopharmacol200515Suppl 3S38
   Google Scholar
• StiglerKAEricksonCAMullettJEPoseyDJMcDougleCJPaliperidone for irritability in autistic disorderJ Child Adolesc Psychopharmacol2010201757820166801
   PubMed Web of Science ®Google Scholar
• StiglerKAMullettJEEricksonCAPoseyDJMcDougleCJPaliperidone for irritability in adolescents and young adults with autistic disorderPsychopharmacology (Berl)2012223223724522549762
   PubMed Web of Science ®Google Scholar
• LoebelABramsMGoldmanRSLurasidone for the treatment of irritability associated with autistic disorderJ Autism Dev Disord20164641153116326659550
   PubMed Web of Science ®Google Scholar
• EngelhardtDMPolizosPWaizerJHoffmanSPA double-blind comparison of fluphenazine and haloperidol in outpatient schizophrenic childrenJ Autism Child Schizophr1973321281374583792
   PubMedGoogle Scholar
• CampbellMAndersonLTMeierMA comparison of haloperidol and behavior therapy and their interaction in autistic childrenJ Am Acad Child Psychiatry1978174640655370186
   PubMedGoogle Scholar
• CampbellMAndersonLTSmallAMPerryRGreenWHCaplanRThe effects of haloperidol on learning and behavior in autistic childrenJ Autism Dev Disord19821221671757174605
   PubMed Web of Science ®Google Scholar
• AndersonLTCampbellMAdamsPSmallAMPerryRShellJThe effects of haloperidol on discrimination learning and behavioral symptoms in autistic childrenJ Autism Dev Disord19891922272392663834
   PubMed Web of Science ®Google Scholar
• PerryRCampbellMAdamsPLong-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administrationJ Am Acad Child Adolesc Psychiatry198928187922914841
   PubMed Web of Science ®Google Scholar
• ArmenterosJLAdamsPBCampbellMEisenbergZWHaloperidol-related dyskinesias and pre- and perinatal complications in autistic childrenPsychopharmacol Bull19953123633697491393
   PubMedGoogle Scholar
• HirotaTVeenstra-VanderweeleJHollanderEKishiTAntiepileptic medications in autism spectrum disorder: a systematic review and meta-analysisJ Autism Dev Disord201444494895724077782
   PubMed Web of Science ®Google Scholar
• HubandNFerriterMNathanRJonesHAntiepileptics for aggression and associated impulsivityCochrane Database Syst Rev20102CD00349920166067
   PubMed Web of Science ®Google Scholar
• HellingsJAWeckbaughMNickelEJA double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disordersJ Child Adolesc Psychopharmacol200515468269216190799
   PubMed Web of Science ®Google Scholar
• LewitzkaUSeverusEBauerRRitterPMüller-OerlinghausenBBauerMThe suicide prevention effect of lithium: more than 20 years of evidence-a narrative reviewInt J Bipolar Disord2015313226183461
   PubMed Web of Science ®Google Scholar
• CampbellMFishBKoreinJShapiroTCollinsPKohCLithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young childrenJ Autism Child Schizophr1972232342634567547
   PubMedGoogle Scholar
• KerbeshianJBurdLFisherWLithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatologyJ Clin Psychopharmacol1987764014053429701
   PubMed Web of Science ®Google Scholar
• SteingardRBiedermanJLithium responsive manic-like symptoms in two individuals with autism and mental retardationJ Am Acad Child Adolesc Psychiatry19872669329352892825
   PubMed Web of Science ®Google Scholar
• SiegelMBeresfordCABunkerMPreliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorderJ Child Adolesc Psychopharmacol201424739940225093602
   PubMed Web of Science ®Google Scholar
• Deepmala SlatteryJKumarNClinical trials of N-acetylcysteine in psychiatry and neurology: a systematic reviewNeurosci Biobehav Rev20155529432125957927
   PubMed Web of Science ®Google Scholar
• BerkMMalhiGSGrayLJDeanOMThe promise of N-acetylcysteine in neuropsychiatryTrends Pharmacol Sci201334316717723369637
   PubMed Web of Science ®Google Scholar
• JamesSJMelnykSJerniganSMetabolic endophenotype and related genotypes are associated with oxidative stress in children with autismAm J Med Genet B Neuropsychiatr Genet2006141B894795616917939
   PubMed Web of Science ®Google Scholar
• EricksonCAMcDougleCJStiglerKAPoseyDJGlutamatergic function in autismHeresco-LevyUGlutamate in Neuropsychiatric DisordersTrivandrum, KeralaResearch Signpost2008
   Google Scholar
• HardanAYFungLKLiboveRAA randomized controlled pilot trial of oral N-acetylcysteine in children with autismBiol Psychiatry2012711195696122342106
   PubMed Web of Science ®Google Scholar
• GhanizadehAMoghimi-SaraniEA randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disordersBMC Psychiatry20131319623886027
   PubMed Web of Science ®Google Scholar
• NikooMRadniaHFarokhniaMMohammadiMRAkhondzadehSN-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safetyClin Neuropharmacol2015381111725580916
   PubMed Web of Science ®Google Scholar
• PoseyDJMcDougleCJThe pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disordersHarv Rev Psychiatry200082456310902094
   PubMed Web of Science ®Google Scholar
• PankseppJSahleyTLPossible brain opioid involvement in disrupted social intent and language development of autismSchoplerEMesibovGBNeurobiological Issues in AutismNew York, NYPlenum Press1987
   Google Scholar
• CampbellMAndersonLTSmallAMNaltrexone in autistic children: behavioral symptoms and attentional learningJ Am Acad Child Adolesc Psychiatry1993326128312918282676
   PubMed Web of Science ®Google Scholar
• RoyARoyMDebSUnwinGRoyAAre opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic reviewJ Intellect Disabil Res201559429330624589346
   PubMed Web of Science ®Google Scholar
• AdlerBAWinkLKEarlyMDrug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review studyAutism201519110210624571823
   PubMed Web of Science ®Google Scholar
• SchubartJRCamachoFLeslieDPsychotropic medication trends among chidren and adolescents with autism psectrum disorder in the Medicaid programAutism201418663163724165274
   PubMed Web of Science ®Google Scholar
• WinkLKPedapatiEVHornPSMcDougleCJEricksonCAMultiple antipsychotic medication use in autism spectrum disorderJ Child Adolesc Psychopharmacol Epub10142015
   Web of Science ®Google Scholar
• GallegoJANielsenJDe HertMKaneJMCorrellCUSafety and tolerability of antipsychotic polypharmacyExpert Opin Drug Saf201211452754222563628
   PubMed Web of Science ®Google Scholar
• GhaleihaAAsadabadiMMohammadiMRMemantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trialInt J Neuropsychopharmacol201316478378922999292
   PubMed Web of Science ®Google Scholar
• GhaleihaAMohammadiEMohammadiMRRiluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trialPaediatr Drugs201315650551423821414
   PubMed Web of Science ®Google Scholar
• MohammadiMRYadegariNHassanzadehEDouble-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized studyClin Neuropharmacol201336617918424201232
   PubMed Web of Science ®Google Scholar
• WinkLKEricksonCAStiglerKAMcDougleCJRiluzole in autistic disorderJ Child Adolesc Psychopharmacol201121437537921823915
   PubMed Web of Science ®Google Scholar
• EricksonCAChambersJEMemantine for disruptive behavior in autistic disorderJ Clin Psychiatry2006676100016848669
   PubMed Web of Science ®Google Scholar
• EricksonCAVeenstra-VanderweeleJMMelmedRDSTX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label studyJ Autism Dev Disord201444495896424272415
   PubMed Web of Science ®Google Scholar
• BronsardVPaulCPreySWhat are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literatureJ Eur Acad Dermatol Venereol201024Suppl 2172220443996
   PubMed Web of Science ®Google Scholar
• StiglerKAMcDougleCJPharmacotherapy of irritability in pervasive developmental disordersChild Adolesc Psychiatr Clin N Am2008174739752viiviii18775367
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionAutism Spectrum Disorder, Data and StatisticsAtlanta, GACenters for Disease Control and Prevention2014 Available from: http://www.cdc.gov/ncbddd/autism/data.htmlAccessed April 26, 2016
   Google Scholar
• MinshawiNWinkLKShafferRA randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disordersMol Autism201672126753090
   PubMed Web of Science ®Google Scholar